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journa l homepage : www.e lsev ie r . com/ loca te / rmedLETTER TO THE EDITORHemoptysis as a presenting sign of multiple myelomaMultiple myeloma (MM) is a malignant plasma cell disorder
characterized by anemia, monoclonal gammopathy in
serum and/or urine, bone pain, hypercalcemia, osteolytic
lesions, hyper viscosity, renal failure.1 Hemoptysis is
coughing up blood originating from the lower respiratory
tract. There are multiple causes of hemoptysis, originating
from airway, parenchymal and cardiovascular diseases, and
other causes. Diagnostic examinations include patient
history, physical examination, bronchoscopy, laboratory
tests, chest X-ray, computed tomography (CT) of the chest,
pulmonary angiography, aortography, and angiography of
the bronchials and other thoracic systemic arteries. Bron-
choscopy together with clinical and radiological examina-
tions indicates the part of the lung bleeding, yet the cause
of hemoptysis cannot be determined in 20e30% of cases.2
To our knowledge we did not notice any MM case who has
hemoptysis as a first symptom in literatures.
A 49 years old female patient referenced to the clinic
with hemoptysis mixed with white colored phlegm which
started 15 days ago. Hemoptysis occurred randomly in
a day and accrued by coughing. She did not describe any
fever, loss of weight or perspiration at night. Physical
examination of the patient was normal except paleness.
In the patient’s history there wasn’t any chronical disease
or no routine drug use. In laboratory tests; hemoglobin
7.6 g/dl, hematocrit 22.3%, platelet 326 000 mm3, WBC
6000 mm3, MCV 80 fL, plasma iron 46 mg/dl, percentage
saturation of iron 24, ferritin 45.4 ng/ml, prothrombin
time 14.5 s (normal range: 10e15 s), active partial
thrombin time 28 s (normal range: 23e34), lactate
dehydrogenase 134 U/L (normal range: 125e243), kidney
functions, calcium level and full urine test were normal.
Total protein 11.7 g/dl, albumin 3 g/dl, globulin 8.7 g/dl
and immune globulin (Ig) G was recorded as 8.4 mg/dl. A
monoclonal M pick was observed in electrophoresis of
protein. Immune electrophoresis valuated as IgG kappa
paraproteinemia. B2-microglobulin ratio was 8.89 mg/L.
Aspiration and biopsy of marrow revealed plasma cell
ratio 42%. Multiple osteolytic lesions determined at direct
radiography of bones (craniography, pelvic graphy) and
spiral CT of thorax. Purified protein derivative recorded
as negative (4 mm). Direct lung radiography valued as
normal. There were no plasmacytoma in CT of thorax.0954-6111/$ - see front matter Crown Copyright ª 2008 Published by E
doi:10.1016/j.rmed.2008.07.028Bronchoalveolar irrigation was normal. There wasn’t any
sign for an infection. There was no acid resistant bacteria.
The accumulation of amyloid was not observed in the biopsy
with Congo red under polarized light from trachea and
pulmonary parenchymal as randomly. Cryoglobulin has not
been detected at the patient who has negative anti-HCV and
HbsAg. Platelet aggregation with ADP, collagen, epinephrine
and ristocetin was normal. Otorhinolaryngologic examina-
tion did not explain any cause of hemoptysis. pH of
hemoptysis was 8. Upper gastrointestinal tract endoscopy
was normal. It was stage IIIA due to MM IgG kappa Duriee
Salmon Staging System of International Myeloma Working
Group.1 International prognostic index was 3. Hemoptysis
continued during this period. Vincristine, doxorubicin,
dexamethasone and zoledronic acid given as treatment to
the patient. After the second dose of treatment, hemoptysis
symptom disappeared. The patient responded to treatment
with biochemically fall in IgG M protein approximately as
50%. Autologous hematopoietic stem cell transplantation
was planned for the patient.
Hemoptysis has been observed as a first sign for some
diseases with rising of globulin like tracheobronchial
amyloidosis, cryoglobulinemia and vasculitis.3e5 Patients
presenting with tracheobronchial amyloidosis have symp-
toms similar to those caused by various airway disorders.
Tracheobronchial amyloidosis is not typically associated
with systemic amyloidosis or pulmonary parenchymal
involvement.3 The inflammatory process involving the
alveolar capillary walls may result in severe alveolar
hemorrhage and consequently lead to a grave outcome.4,5
MM may rarely have different clinical manifestation.
Bleeding has been reported in 15% of patients with IgG
myeloma. The bleeding may result from anoxia and throm-
bosis in capillary circulation, perivascular amyloid, and/or
an acquired coagulopathy, such as coagulation factor X
deficiency, in primary amyloidosis.1 We suggest that when
evaluating causes of hemoptysis MM should be kept in mind.
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